# Clinical examination of the cardiovascular diseases # --- [](https://cardio-balance-ph.store-best.net) <div style="height:500px;"></div> ## The risk of developing cardiovascular diseases 1 ## Ang pagkontrol sa presyon ay isang napakahalagang gawain, dahil ang pag-inom ng mga tableta na nakakatulong sa pagpapanatili ng normal na mga indikador ay maaaring magbigay ng araw-araw na komportableng buhay, upang maiwasan ang panganib ng hypertensive crisis, atake sa puso, at stroke. Ang mga gamot para sa kontrol ng presyon ay medyo malawakang makukuha sa mga botika, pero tanging ang doktor lang ang makakapili ng tamang gamot na angkop sa therapy. Lahat ng grupo ng gamot para pababain ang presyon ay may iba't ibang mekanismo ng epekto, side effects, at may kaunting posibilidad ng pagkadepende. Ang tamang pagpili ng gamot ay nagbibigay ng mabilis at tuloy-tuloy na resulta, at ang eksperimento sa sarili sa pag-inom ng gamot ay may mataas na posibilidad ng biglaang karamdaman, sakit sa puso at daluyan ng dugo, at sa matinding kaso, maaaring magdulot ng kamatayan. Heart healthy life full of energy: Protect against cardiovascular diseases! Each year, call for heart and circulatory diseases, millions of lives around the world. The risk of its development is often due to lifestyle-related factors can be influenced — and in your hands. Knowledge is the first step to prevention. Avoid risk factors such as: unhealthy diet, Lack of movement, Smoking chronic Stress, excess consumption of alcohol. Our offer: A comprehensive prevention program for your cardiovascular System! With our services you will receive: An individual health advice by experienced cardiologists. A tailor-made exercise program of gentle Walking up to the heart-strengthening cardio training. Nutrition advice: Learn how to tailor your diet on your heart. Regular checkups for early detection of risk factors. Strategies for stress management and relaxation techniques. Our goal: help you to reduce the risk of cardiovascular disease significantly and to improve your well-being in a sustainable way. Call to Action: Sign up today and take the first step to a healthier heart! 📞 Contact us at: 🌐 Visit our Website: https://cardio.nashi-veshi.ru Under the line: You invest in your heart you invest in your life. Minsan lang na biglaang pagtaas ng presyon o bahagyang mataas na resulta ay hindi palaging nangangailangan ng agarang pag-inom ng tableta. Lahat ng rekomendasyon ng mga espesyalista at ang mga magagamit na paraan ng pag-iwas ay mukhang simple lang, pero sa aktwal na buhay, ang maingat na pag-aalaga sa kalusugan ng dugo at sistema ng puso ay nakakaiwas sa biglaan at sobrang hindi kanais-nais na pagtaas ng presyon. > A sedentary lifestyle, alcohol, and cigarette consumption increase body weight which in turn hinders healthy blood circulation and strength of arteries and veins. This results in high blood pressure. So, if you’re overweight, you need to monitor your blood pressure frequently.  <a href="http://gumpasteflowersbysuzette.com/fckeditorfile/7171-acute-cardiovascular-disease-symptoms..xml">Presyong pang-promosyon</a> Ang mga modernong gamot sa pag-imprenta ay hinahati sa 10 iba't ibang grupo ayon sa kanilang mekanismo ng pagkilos. Pagkatapos suriin ng doktor ang mga reklamo ng pasyente at ang resulta ng mga pagsusuri, nagrereseta siya ng isa o higit pang gamot, na hindi dapat baguhin nang mag-isa. Ang mga gamot sa puso at daluyan ng dugo ay hindi kabilang sa mga puwedeng irekomenda sa kaibigan. Ang maling desisyon ay maaaring magdulot ng malungkot na kahihinatnan. Lahat ng gamot na pampababa ng presyon ng dugo ay kailangan ng reseta. Sa artikulong ito, tinitingnan natin ang kanilang modernong klasipikasyon base sa mga aktibong sangkap at sa paraan ng epekto nito sa katawan. <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">Presyong pang-promosyon</a> Heart healthy life full of energy: a Modern clinical studies for your cardiovascular System Ensure you on time for your heart? Cardiovascular diseases are among the most common health risks in the world, but early diagnosis can save lives. Our modern heart center offers a comprehensive clinical examination of the cardiovascular system that gives you clarity about the state of your heart. What is included in our investigation? detailed medical history and risk factor analysis; physical examination with measurement of blood pressure and pulse analysis; ECG (electrocardiogram) to assess the heart rhythm activity; Ultrasound examination of the heart (echocardiography) for the assessment of cardiac structure and function; Load tests (e.g., treadmill test) for the analysis of cardiac performance under stress; if necessary, additional tests such as long‑term ECG or long‑term blood pressure measurement. Why do we need to investigate? Experienced Team: heart specialist and cardiologist with years of experience. High modern technology: Precise diagnostic devices for reliable results. Quick results: evaluation and individual consultation in the shortest time. Patient-centered approach: your health is our top priority. Prevention is better than cure. Take advantage of the Chance to keep your heart healthy! Early screening can detect dangerous diseases before they cause serious problems. Appointment: Call us or write an E‑Mail to arrange an appointment for your individual clinical examination of the Heart. Your heart deserves the best care — trust the experts. ## Cardio Balance of the heart and circulatory diseases ## Vitagerpavak and its relevance for cardiac and vascular disease: An analysis of current research results The treatment and prevention of heart and vascular diseases and represents one of the most important challenges of modern medicine. In this context, immunological approaches are gaining increasing interest, in particular, the possible role of vaccines as Vitagerpavak in the influence of risk factors for cardiovascular disease. Vitagerpavak is a vaccine, which was originally developed for the prophylaxis of herpes simplex infections. It contains inactivated virus particles of the Herpes simplex Virus (HSV) and to strengthen the immune response against these pathogens. Recent studies suggest, however, that a chronic infection with HSV and other herpes viruses may be associated with an increased risk for atherosclerotic diseases. Pathophysiological Bases Atherosclerosis, the basis of many cardiovascular diseases, is no longer valid today only as a lipid-induced vascular changes. Inflammatory processes play a Central role in the progression of Plaque formation and in the instability of progression. Herpes viruses, such as HSV‑1 and cytomegalovirus (CMV) can cause various tissues, including the vascular wall, persist, and there is a chronic, subclinical inflammation. This chronic inflammation can exert the following effects: Activation of macrophages and T‑cells in the vascular wall; Increased production of proinflammatory cytokines (e.g., TNF‑α, IL‑6); Impairment of endothelial function; Amplification of the Oxidation of LDL cholesterol. Potential mechanisms of action of Vitagerpavak Vaccination with Vitagerpavak a specific stimulated immune response against HSV. A possible protective effect against cardiovascular disease could pass through the following mechanisms: Reduction of viral load: An effective immune response can prevent the reactivation and spread of HSV. As a result, the chronic inflammation is attenuated in the vascular wall. Modulation of systemic inflammation: A controlled immune response could affect the balance between pro‑ and anti-inflammatory cytokines positively. Protection of the endothelial cells By the reduction of viral damage to the function of the vascular endothelium could be preserved, which delays the development of atherosclerosis. Previous Research Results Epidemiological studies show a correlation between serological Evidence of HSV infection and the Occurrence of coronary heart disease (CHD). In animal models, it could be demonstrated that vaccination against CMV may reduce the development of Atheroskleroseplaquen. Whether these results are directly on Vitagerpavak and HSV-transferable, must be investigated in clinical intervention studies. Conclusions and Outlook The vaccine Vitagerpavak also could represent his primary anti — viral effect — a new approach to the prevention of heart and vascular diseases. The underlying mechanism is the reduction of a virus-induced chronic inflammation, which contributes to atherosclerosis would be. Currently, randomized, controlled clinical trials that demonstrate the direct cardioprotective effect of Vitagerpavak missing. Further research is necessary to evaluate the efficacy and safety of such a prevention approach. The study of the interactions between viral infections, the immune system, and cardiovascular disease remains a promising field of research. <a href="http://digitalpolicycouncil.com/imagenes/acute-cardiovascular-disease-symptoms..xml">The risk of developing cardiovascular diseases 1</a> Clinical examination of the cardiovascular diseases. <a href="http://g-house.com.tw/userfiles/tablets-of-moderate-hypertension.xml">The risk of developing cardiovascular diseases 1</a> <a href="http://factorycontrol.nl/userfiles/somatic-diseases-of-the-circulatory-system.xml">Cardio Balance of the heart and circulatory diseases</a> <a href="http://gosselindesign.com/images/from_fckeditor/high-blood-pressure-tablets-for-the-continuous-application-of-pressure-9113.xml">The mortality due to diseases of the circulatory System</a> <a href="http://ersllc.com/userfiles/cardiovascular-disease-and-life-expectancy-1601.xml">http://ersllc.com/userfiles/cardiovascular-disease-and-life-expectancy-1601.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://write.frame.gargantext.org/s/S1eo1eFGGe">https://write.frame.gargantext.org/s/S1eo1eFGGe</a> <a href="https://pad.koeln.ccc.de/s/NrftdsLJY">https://pad.koeln.ccc.de/s/NrftdsLJY</a> <a href="https://hedgedoc.nrp-nautilus.io/s/ELGQlqfrbP">https://hedgedoc.nrp-nautilus.io/s/ELGQlqfrbP</a> <a href="https://md.cortext.net/s/BQdEydzpL">https://md.cortext.net/s/BQdEydzpL</a> <a href="https://pad.dominick-leppich.de/s/Z3VpepurY">https://pad.dominick-leppich.de/s/Z3VpepurY</a> <a href="https://doc.neutrinet.be/s/3U8WOn52RT">https://doc.neutrinet.be/s/3U8WOn52RT</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://md.rappet.xyz/s/qDdtrYOvUY">https://md.rappet.xyz/s/qDdtrYOvUY</a> <a href="https://hdoc.csirt-tooling.org/s/KdA_aBf_4i">https://hdoc.csirt-tooling.org/s/KdA_aBf_4i</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://pad.gusted.xyz/s/2ZbIRVhOB">https://pad.gusted.xyz/s/2ZbIRVhOB</a> <a href="https://pad.medialepfade.net/s/FJU2vwVz9">https://pad.medialepfade.net/s/FJU2vwVz9</a> <a href="https://doc.cisti.org/s/RliAVsC-g0">https://doc.cisti.org/s/RliAVsC-g0</a> <a href="https://md.infs.ch/s/xdj2o5KT-O">https://md.infs.ch/s/xdj2o5KT-O</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://notes.rabjerg.de/s/H1NzMeKfzl">https://notes.rabjerg.de/s/H1NzMeKfzl</a> <a href="https://hedge.grin.hu/s/D9SjTD_cvA">https://hedge.grin.hu/s/D9SjTD_cvA</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://pads.tobast.fr/s/n05niOTZGS">https://pads.tobast.fr/s/n05niOTZGS</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://md.coredump.ch/s/choiwONCV">https://md.coredump.ch/s/choiwONCV</a> <a href="https://om-office.de/s/H1RGzlKfGx">https://om-office.de/s/H1RGzlKfGx</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://n.jo-so.de/s/4YEAtfuAF">https://n.jo-so.de/s/4YEAtfuAF</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://pad.mytga.de/s/NT-6Bf5lR">https://pad.mytga.de/s/NT-6Bf5lR</a> <a href="https://md.micronited.de/s/rys7GgKffe">https://md.micronited.de/s/rys7GgKffe</a> <a href="https://pad.yuka.dev/s/QgviPhadK2">https://pad.yuka.dev/s/QgviPhadK2</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://hedgedoc.stanleysolutionsnw.com/s/zIcw02tLMO">https://hedgedoc.stanleysolutionsnw.com/s/zIcw02tLMO</a> <a href="https://pad.cttue.de/s/rrEkMSzaO">https://pad.cttue.de/s/rrEkMSzaO</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://doc.spiegie.de/s/ZsUHslBkz">https://doc.spiegie.de/s/ZsUHslBkz</a> <a href="https://hedgedoc.inqbus.de/s/RkNFiAx4G">https://hedgedoc.inqbus.de/s/RkNFiAx4G</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://notes.llgoewer.de/s/tMTNqkUPq">https://notes.llgoewer.de/s/tMTNqkUPq</a> <a href="https://hedgedoc.private.coffee/s/w8OCyUw7m">https://hedgedoc.private.coffee/s/w8OCyUw7m</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://md.coredump.ch/s/6E-cghC8Q">https://md.coredump.ch/s/6E-cghC8Q</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://md.nolog.cz/s/qdDUhMpEM">https://md.nolog.cz/s/qdDUhMpEM</a> <a href="https://md.gafert.org/s/-7ECM4LBK">https://md.gafert.org/s/-7ECM4LBK</a> <a href="https://pad.multiplace.org/s/S1xLMltzGe">https://pad.multiplace.org/s/S1xLMltzGe</a> <a href="https://hack.utopia-lab.org/s/tR0wPwwk9">https://hack.utopia-lab.org/s/tR0wPwwk9</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://md.interhacker.space/s/So58mV0LY">https://md.interhacker.space/s/So58mV0LY</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> <a href="https://pad.demokratie-dialog.de/s/C72bm4CQyu">https://pad.demokratie-dialog.de/s/C72bm4CQyu</a> <a href="https://pads.dgnum.eu/s/EoR-73NSXE">https://pads.dgnum.eu/s/EoR-73NSXE</a> <a href="http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml">http://gemmacapitalgroup.com/foto/marker-for-cardiovascular-disease.xml</a> ## The mortality due to diseases of the circulatory System ## The mortality due to diseases of the cardiovascular system ErHANDLUNG OF CARDIOVASCULAR DISEASE (CVD) is one of the most important health challenges of the modern society. According to the data of the world health organization (WHO), diseases of the circulatory system are the leading cause of death worldwide and cause a year, approximately 17.9 million deaths, equivalent to approximately 32% of all deaths globally. Epidemiological situation in Germany In Germany, statistical surveys show that CVD is the main cause of mortality. According to the Robert Koch Institute (RKI) and the German Federal Statistical office: about 40% of deaths in Germany to go back to cardio‑ vascular diseases; the highest mortality rate is recorded in the case of persons over the age of 65 years; Men in most age groups have a higher mortality rate than women, which is partly explained by the different life-style factors and biological differences. The main causes and risk factors Among the most common causes of death in the context of CVD: Heart Attack (Myocardial Infarction); Stroke (Cerebral Stroke); Heart Failure (Congestive Heart Failure); arrhythmic deaths. The most important modifiable risk factors include: arterial hypertension; Hyperlipidemia; Diabetes mellitus type 2; Tobacco consumption; lack of physical activity; unhealthy diet; Overweight and obesity. Non-modifiable risk factors are: Age; Gender; family history of early cardiovascular disease. Trends and developments Despite progress in diagnostics and therapy, the absolute number of deaths by heart disease, which is influenced mainly by the ageing of the population. At the same time, age standardization of death rates shows a declining Trend: since the 1980s, the standardised death rate decreased due to cardiovascular diseases in Germany, more than 50%; this is due to the improvement of medical care, the introduction of prevention programs and the reduction of risk factors (e.g., the reduction of tobacco consumption). Prevention and Intervention An effective reduction of the mortality requires a Multi‑level approach: Primary prevention: education on healthy lifestyle, blood pressure and cholesterol Screening, vaccination (for example, against the flu to avoid complications in high-risk patients). Secondary prevention: early diagnosis and continuous therapy in the case of already existing diseases (e.g., use of medication after a heart attack). Health policy: a legal measures to reduce the consumption of tobacco, salt and sugar reduction in food that promote movement in the cities. Conclusion The mortality by diseases of the circulatory system in Germany, a Central challenge for the health, although the standardized mortality rates have been falling for decades. A sustainable reduction requires the development of prevention strategies, the strengthening of health education and improving access to medical care for all population groups. The control of risk factors at the individual and societal level is the key to further reduction in cardiovascular mortality. Would you like me to make a certain section in greater detail or further data and sources to add?